Showing results (1-10 of 367) with videos related to

Sort By:
Pageof 37
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 1, 2018
The future of choline PET in the era of prostate specific membrane antigenLaura Evangelista, Lea Cuppari, Fabio Zattoni, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 9, 2016
The effects of androgen deprivation therapy on the 18F-Chcoline uptake in prostate cancer patients undergoing neoadjuvant treatmentLaura Evangelista, Fabio Zattoni, Andrea Guttilla, et al.
Nuclear Medicine Communications|August 24, 2016
Radiolabeled choline PET/CT before salvage lymphadenectomy dissection: a systematic review and meta-analysisLaura Evangelista, Fabio Zattoni, Robert J Karnes, et al.
European Urology|October 6, 2012
Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysisLaura Evangelista, Andrea Guttilla, Fabio Zattoni, et al.
Scandinavian Journal of Urology|February 5, 2015
Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysisLaura Evangelista, Marino Cimitan, Fabio Zattoni, et al.
Nuclear Medicine and Biology|January 26, 2015
¹⁸F-fluoromethylcholine or ¹⁸F-fluoroethylcholine pet for prostate cancer imaging: which is better? A literature revisionLaura Evangelista, Anna Rita Cervino, Andrea Guttilla, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 14, 2015
Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CTPierpaolo Alongi, Maria Picchio, Fabio Zattoni, et al.
Clinical Imaging|March 10, 2017
Fluorocholine PET/CT predicts skeletal progression, skeletal event and cancer specific survival in patients with biochemical relapse for prostate cancerFabio Zattoni, Emanuela Agostini, Francesco Cattaneo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 9, 2020
PET/MRI in prostate cancer: a systematic review and meta-analysisLaura Evangelista, Fabio Zattoni, Gianluca Cassarino, et al.
Clinical Nuclear Medicine|March 15, 2013
Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysisLaura Evangelista, Fabio Zattoni, Andrea Guttilla, et al.
Pageof 37